Clinical Trial Update: A Phase I/II Study With CEA(6D) VRP Vaccine in Patients With Advanced or Metastatic CEA-Expressing Malignancies [Phase 1, Phase 2]

View source ↗

Summary

This update reports the completion of a Phase I/II study evaluating the CEA(6D) VRP Vaccine in patients with advanced or metastatic CEA-expressing cancers, incl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Colorectal Cancer
• Lung Cancer
• Pancreatic Cancer

Drugs mentioned

• CEA(6D) VRP Vaccine (CEA(6D) VRP vaccine)

Snippet

Sponsor: AlphaVax, Inc. | Conditions: Colorectal Cancer, Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED